US FDA approves Regeneron's ultra-rare blood disease drug
US FDA approves Regeneron's ultra-rare blood disease drug
A large health insurer is trying a new way to lower drug costs for millions of members
A large health insurer is trying a new way to lower drug costs for millions of members
US Supreme Court to scrutinize Purdue Pharma bankruptcy settlement
US Supreme Court to scrutinize Purdue Pharma bankruptcy settlement
Supreme Court blocks $6 billion Purdue Pharma opioid settlement and will hear case this fall
Supreme Court blocks $6 billion Purdue Pharma opioid settlement and will hear case this fall
Purdue asks Supreme Court not to block opioid settlement during US appeal
Purdue asks Supreme Court not to block opioid settlement during US appeal
Teva agrees to pay $126 million to US hospitals over opioids
Teva agrees to pay $126 million to US hospitals over opioids
CVS is laying off 5,000 workers
CVS is laying off 5,000 workers
US asks Supreme Court to delay Purdue Pharma bankruptcy settlement
US asks Supreme Court to delay Purdue Pharma bankruptcy settlement
Japan's Takeda beats Q1 profit estimates on mainstay drugs, dengue vaccine
Japan's Takeda beats Q1 profit estimates on mainstay drugs, dengue vaccine
Purdue Pharma bankruptcy can proceed despite potential US Supreme Court appeal
Purdue Pharma bankruptcy can proceed despite potential US Supreme Court appeal
Nvidia invests $50 million in Recursion to train AI models for drug discovery
Nvidia invests $50 million in Recursion to train AI models for drug discovery
US FDA approves BioMarin's gene therapy for hemophilia A
US FDA approves BioMarin's gene therapy for hemophilia A
«123»